British Journal of Clinical Pharmacology · 1989 · 38 citations · 20 references
MedicinePharmacologyToxicologyDrug MetabolismNeuropharmacologyPharmaceutical ToxicologyDrug DispositionDrug-metabolizing EnzymesEnzyme InhibitionIn Vitro PharmacologyMolecular Mechanisms Of ToxicityNeurotoxic MechanismsAnticonvulsant DrugsAnticonvulsant PharmacologyEpoxide Hydrolase ActivityEpoxide HydrolasesEpoxide MetabolitesHepatic Microsomal MetabolismMicrosomal Enzyme ActivityMicrosomal Enzyme-mediated Metabolism
The formation of cytotoxic metabolites from the anticonvulsants phenytoin and carbamazepine was investigated in vitro using a hepatic microsomal enzyme system and human mononuclear leucocytes as target cells. Both drugs were metabolised to cytotoxic products. In order to assess the structural requirements for this bioactivation, a series of structurally related compounds was investigated. It was found that molecules which contain either an amide function or an aryl ring may undergo activation in vitro, but only the metabolism-dependent toxicity of the latter is potentiated by pre-treatment of the target cells with an epoxide hydrolase inhibitor. Taken collectively, these data are consistent with the concept that reactive epoxide metabolites of both phenytoin and carbamazepine may produce toxicity in individuals with an inherited deficiency in epoxide hydrolase.
20
The Carbon Monoxide-binding Pigment of Liver Microsomes
Tsuneo Omura, Ryo Sato · Journal of Biological Chemistry · 1964 · 11.8K citations · Full text
Arene Oxides: A New Aspect of Drug Metabolism
D. M. JERINA, John W. Daly · Science · 1974 · 1K citations
Drug disposition and drug hypersensitivity
B. Kevin Park, John W. Coleman, Neil R. Kitteringham · Biochemical Pharmacology · 1987 · 198 citations
K. Lertratanangkoon, M. G. Horning · Drug Metabolism and Disposition · 1982 · 183 citations